CompletedPhase 3

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

NCT00660387

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Site Reference ID/Investigator# 45931

Birmingham, Alabama, United States

+13 additional locations

Save this trial

Site Reference ID/Investigator# 45931Birmingham, Alabama, United States
Site Reference ID/Investigator# 45910Fountain Valley, California, United States
Site Reference ID/Investigator# 45925Oceanside, California, United States
Site Reference ID/Investigator# 45912Port Charlotte, Florida, United States
Site Reference ID/Investigator# 45935Chicago, Illinois, United States
Site Reference ID/Investigator# 45930Lexington, Kentucky, United States
Site Reference ID/Investigator# 45934New York, New York, United States
Site Reference ID/Investigator# 45929Winston-Salem, North Carolina, United States
Site Reference ID/Investigator# 45908Cincinnati, Ohio, United States
Site Reference ID/Investigator# 45922Cleveland, Ohio, United States
Site Reference ID/Investigator# 45915Kirkland, Washington, United States
Site Reference ID/Investigator# 45904Auckland, New Zealand
Site Reference ID/Investigator# 45902Christchurch, New Zealand
Site Reference ID/Investigator# 45905Hamilton, New Zealand